Home » Topics » BioWorld Science

BioWorld Science
RSS

BetterLife reports data from in vivo oral bioavailability and food-effect PK study with BETR-001

Jan. 19, 2022

ProMIS initiates program to develop monoclonal antibodies to treat schizophrenia

Jan. 19, 2022

Eisbach Bio and MD Anderson partner to target synthetic lethality in cancer

Jan. 19, 2022

Once-daily dermal administration of Epoladerm well tolerated in four preclinical studies

Jan. 19, 2022

Sodium salt of a quinoline derivative shows anticancer efficacy in vivo

Jan. 19, 2022

Yes targeting useful for treatment of HCC, researchers suggest

Jan. 19, 2022

Ortho-hIL-2/ortho-hIL-2Rbeta pair enhances antitumor efficacy of engineered T cells

Jan. 19, 2022

New kappa-opioid receptor agonists identified at Humanwell Pharmaceutical US

Jan. 19, 2022

Charite-Universitaetsmedizin Berlin, Sapreme Technologies present new saponin derivatives

Jan. 19, 2022

Idorsia Pharmaceuticals discovers Kv7 potassium channel activators

Jan. 19, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...